Delivery Order SPE2DB20D3103-SPE2DB24FP8Q9

Award Date 8/12/24
Potential Completion Date 9/3/24
Potential Value $78K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order valued at $7,707.76 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a medical product, with a performance period ending on February 14, 2025. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,684.92 Firm Fixed Price Delivery Order contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, valued at $7,765.20, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. It is a firm-fixed-price delivery order contract with a performance period ending on November 7, 2024. The contract was awarded on October 17, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Corporate Office Division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $27,954.72 firm fixed price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a medication, to government facilities. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB91F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,634.70 firm fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a medication, with a performance period through June 2, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,684.92, is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a medical product. The contract has an ultimate completion date of April 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This contract award to AmerisourceBergen Drug Corp provides for the delivery of AVEED 750 MG/3 ML VIAL 3ML pharmaceutical products to support federal healthcare programs. The $1,926.94 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to supply a comprehensive range of...
The U.S. government awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $18,730.08 Firm Fixed Price delivery order contract (SPE2DX15D1053|SPE2DX24F6FMR) to supply 4563439394 - AVEED 750 MG/3 ML VIAL 3ML. This contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency responsible for providing medical supplies to military healthcare programs. Amerisourcebergen also holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The order is for $15,530.40 and covers the supply of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. The overall IDC with Amerisourcebergen is valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical commodities to support military treatment...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price valued at $7,993.75, and the ultimate completion date is February 25, 2025. The contract covers a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP8Q9
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $77,652 firm fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of September 3, 2024.

This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 2/27/25, 11:45 AM